Pediamycin: Uses, Dosage, Side Effects, and Warnings
Table of Contents
Introduction to Pediamycin
Pediamycin is a macrolide antibiotic used to treat various bacterial infections, particularly those affecting the respiratory tract. It is a form of erythromycin, specifically erythromycin ethylsuccinate, developed for pediatric use.
Mechanism of Action
As a macrolide antibiotic, Pediamycin works by inhibiting bacterial protein synthesis. It binds to the 50S ribosomal subunit, preventing the translocation of peptidyl tRNA and ultimately leading to the cessation of bacterial growth and reproduction. Pediamycin is particularly effective against gram-positive bacteria and some gram-negative bacteria, such as Streptococcus, Staphylococcus, and Haemophilus influenzae [1].
Medical Uses of Pediamycin
Pediamycin is primarily prescribed for the treatment of respiratory tract infections in children, such as bronchitis, pneumonia, and tonsillitis. It may also be used to treat other bacterial infections susceptible to erythromycin, including skin infections and pertussis (whooping cough) [2].
Dosage and Administration
Pediamycin is available as granules for oral suspension, which must be reconstituted with water before administration. The recommended dosage varies depending on the child’s weight and the severity of the infection but typically ranges from 30-50 mg/kg/day, divided into two to four doses. It is crucial to follow the prescribing physician’s instructions and complete the entire course of treatment, even if symptoms improve [3].
Side Effects and Contraindications
Common side effects of Pediamycin include gastrointestinal distress, such as nausea, vomiting, and diarrhea. Less frequently, patients may experience allergic reactions, hearing loss, or liver dysfunction. Pediamycin should be used with caution in patients with impaired hepatic function or a history of allergies to macrolide antibiotics.
Brand Names and Synonyms
Pediamycin is a trade name for erythromycin ethylsuccinate, which is marketed under various other brand names, including Erythrocin, E-Mycin, Ethril, Ilosone, and E.e.s. The drug is also known by its chemical name, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione.
Drug Interactions
Pediamycin may interact with various other medications, including theophylline, carbamazepine, and digoxin. Concomitant use of Pediamycin with these drugs may require dose adjustments or increased monitoring. Pediamycin can also interact with other macrolide antibiotics, lincosamides, and chloramphenicol, potentially leading to additive or antagonistic effects.
Patient Information
Patients should be advised to take Pediamycin as prescribed, with or without food. If a dose is missed, it should be taken as soon as possible, unless it is almost time for the next dose. In such cases, the missed dose should be skipped. Patients should be informed of the potential side effects and instructed to contact their healthcare provider if they experience severe or persistent adverse reactions. Completing the entire course of treatment is essential to prevent the development of antibiotic-resistant bacteria.
